Clinical Trials Browser

NCT02381561 2026-03-18

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Phase 1 Active not recruiting

19 enrolled

Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT04929028 2026-03-18

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Phase 2 Recruiting

40 enrolled

Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT02921256 2025-12-04

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Phase 2 Completed

363 enrolled 16 charts

Gastrointestinal

Rectal Neoplasms

NCT04703101 2025-11-10

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

Phase 1 Recruiting

25 enrolled

Gastrointestinal

Rectal Neoplasms

NCT04104139 2025-10-27

TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer

Phase 1 Active not recruiting

19 enrolled

Gastrointestinal

Rectal Neoplasms

NCT02008656 2025-08-27

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Phase 2 Active not recruiting

358 enrolled

Gastrointestinal

Rectal Neoplasms

NCT05965531 2025-04-29

TASLARC

Phase 2 Recruiting

65 enrolled

Gastrointestinal

Rectal Neoplasms

NCT04380337 2025-02-25

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

Phase 2 Completed

38 enrolled 13 charts

Gastrointestinal

Rectal Neoplasms

NCT02017704 2023-10-17

CORRECT

Phase 2 Completed

9 enrolled 9 charts

Gastrointestinal

Rectal Neoplasms

NCT02860234 2021-07-23

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

Completed

68 enrolled

Gastrointestinal

Rectal Neoplasms

NCT02864849 2021-07-23

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Phase 2 Completed

81 enrolled

Gastrointestinal

Rectal Neoplasms

NCT02270606 2021-07-20

Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer

Phase 1 Completed

14 enrolled

Gastrointestinal

Rectal Neoplasms

NCT02010567 2020-11-03

Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer

Phase 1/2 Terminated

32 enrolled 18 charts

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT04405206 2020-10-14

BJCC-R01

Unknown

54 enrolled

Gastrointestinal

Rectal Neoplasms

NCT04340401 2020-07-09

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Phase 2 Unknown

25 enrolled

Gastrointestinal

Rectal Neoplasms

NCT03258541 2020-05-15

Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy

Phase NA Terminated

2 enrolled

Gastrointestinal

Rectal Neoplasms

NCT03634202 2019-05-15

DESIR

Phase NA Terminated

9 enrolled

Gastrointestinal

Neoplasm Metastasis, Rectal Neoplasms

NCT01729923 2018-01-16

ADAPT

Phase 2 Terminated

27 enrolled 10 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01148056 2017-02-15

Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer

Phase 2 Terminated

2 enrolled 4 charts

Gastrointestinal

Rectal Neoplasms

NCT00392470 2011-05-25

Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer

Phase 1 Unknown

20 enrolled

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT01340508 2011-04-22

Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer

Phase 2 Unknown

63 enrolled

Gastrointestinal

Rectal Neoplasms